86 related articles for article (PubMed ID: 8694540)
1. Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy.
Fernandez-Pol JA
Anticancer Res; 1996; 16(4B):2177-85. PubMed ID: 8694540
[TBL] [Abstract][Full Text] [Related]
2. Expression of metallopanstimulin and oncogenesis in human prostatic carcinoma.
Fernandez-Pol JA; Fletcher JW; Hamilton PD; Klos DJ
Anticancer Res; 1997; 17(3A):1519-30. PubMed ID: 9179190
[TBL] [Abstract][Full Text] [Related]
3. A new assay to screen for head and neck squamous cell carcinoma using the tumor marker metallopanstimulin.
Lee WJ; Keefer K; Hollenbeak CS; Stack BC
Otolaryngol Head Neck Surg; 2004 Oct; 131(4):466-71. PubMed ID: 15467619
[TBL] [Abstract][Full Text] [Related]
4. Increased serum level of RPMPS-1/S27 protein in patients with various types of cancer is useful for the early detection, prevention and therapy.
Fernandez-Pol JA
Cancer Genomics Proteomics; 2012; 9(4):203-56. PubMed ID: 22798506
[TBL] [Abstract][Full Text] [Related]
5. Expression of metallopanstimulin in condylomata acuminata of the female anogenital region induced by papilloma virus.
Xynos FP; Klos DJ; Hamilton PD; Schuette V; Huygens P; Fernandez-Pol JA
Anticancer Res; 1994; 14(3A):773-86. PubMed ID: 8074479
[TBL] [Abstract][Full Text] [Related]
6. Metallopanstimulin is overexpressed in a patient with colonic carcinoma.
Ganger DR; Hamilton PD; Fletcher JW; Fernandez-Pol JA
Anticancer Res; 1997; 17(3C):1993-9. PubMed ID: 9216656
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia.
Ganger DR; Hamilton PD; Klos DJ; Jakate S; McChesney L; Fernandez-Pol JA
Cancer Detect Prev; 2001; 25(3):231-6. PubMed ID: 11425264
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evidence of metallopanstimulin-1 in gastric cancer progression and tumorigenicity.
Wang YW; Qu Y; Li JF; Chen XH; Liu BY; Gu QL; Zhu ZG
Clin Cancer Res; 2006 Aug; 12(16):4965-73. PubMed ID: 16914586
[TBL] [Abstract][Full Text] [Related]
9. Metallopanstimulin as a marker for head and neck cancer.
Stack BC; Hollenbeak CS; Lee CM; Dunphy FR; Lowe VJ; Hamilton PD
World J Surg Oncol; 2004 Dec; 2():45. PubMed ID: 15598348
[TBL] [Abstract][Full Text] [Related]
10. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
11. Metallopanstimulin-1 regulates invasion and migration of gastric cancer cells partially through integrin β4.
Yang ZY; Jiang H; Qu Y; Wei M; Yan M; Zhu ZG; Liu BY; Chen GQ; Wu YL; Gu QL
Carcinogenesis; 2013 Dec; 34(12):2851-60. PubMed ID: 23803695
[TBL] [Abstract][Full Text] [Related]
12. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.
Schwarzenbach H; Stoehlmacher J; Pantel K; Goekkurt E
Ann N Y Acad Sci; 2008 Aug; 1137():190-6. PubMed ID: 18837946
[TBL] [Abstract][Full Text] [Related]
13. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MPS antigens by squamous cell carcinomas of the head and neck: immunohistochemical and serological correlation with FDG positron emission tomography.
Stack BC; Dalsaso TA; Lee C; Lowe VJ; Hamilton PD; Fletcher JW; Fernandez-Pol JA
Anticancer Res; 1999; 19(6C):5503-10. PubMed ID: 10697607
[TBL] [Abstract][Full Text] [Related]
15. Extraribosomal function of metallopanstimulin-1: reducing paxillin in head and neck squamous cell carcinoma and inhibiting tumor growth.
Dai Y; Pierson SE; Dudney WC; Stack BC
Int J Cancer; 2010 Feb; 126(3):611-9. PubMed ID: 19642098
[TBL] [Abstract][Full Text] [Related]
16. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies.
Perabo F; Sharma S; Gierer R; Wirger A; Fimmers R; Steiner G; Adam M; Schultze-Seemann W
Indian J Cancer; 2001 Mar; 38(1):1-7. PubMed ID: 14758878
[TBL] [Abstract][Full Text] [Related]
17. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
[TBL] [Abstract][Full Text] [Related]
18. Novel blood biomarkers of human urinary bladder cancer.
Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760
[TBL] [Abstract][Full Text] [Related]
19. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
20. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
